EXECUTIVE EMPLOYMENT AGREEMENT BETWEEN LAWRENCE LEHOUX AND CEN BIOTECH, INC.Executive Employment Agreement • August 31st, 2022 • Cen Biotech Inc • Pharmaceutical preparations • Ontario
This Executive Employment Agreement (“Agreement”) is entered into as of August 26, 2022, by and between CEN Biotech, Inc. (the “Company”), and Lawrence Lehoux (the “Executive”) and effective as of September 1, 2022 (the “Effective Date”). The parties believe it to be in their best interest to document the terms of the Executive's employment with the Company as follows:
CEN BIOTECH, INC. RESTRICTED STOCK AGREEMENTRestricted Stock Agreement • August 31st, 2022 • Cen Biotech Inc • Pharmaceutical preparations • New York
WHEREAS, as of April 7th, 2021, the Company adopted the CEN Biotech, Inc. 2021 Equity Compensation Plan (the “Plan”), which Plan authorizes, among other things, the grant of restricted shares of the Company’s common stock (“Common Stock”), to directors, officers and employees of the Company and to other individuals; and
CEN BIOTECH, INC. RESTRICTED STOCK AGREEMENTEquity Compensation Plan • August 31st, 2022 • Cen Biotech Inc • Pharmaceutical preparations • New York
WHEREAS, as of April 7th, 2021, the Company adopted the CEN Biotech, Inc. 2021 Equity Compensation Plan (the “Plan”), which Plan authorizes, among other things, the grant of restricted shares of the Company’s common stock (“Common Stock”), to directors, officers and employees of the Company and to other individuals; and
